| Author |
Year |
Total patients |
Overlap patients |
Prevalence |
Diagnostic criteria |
| Chazouilleres et al. [10] |
1998 |
130 |
12 |
9% |
Paris criteria |
| Czaja [2] |
1998 |
162 with AIH |
8 |
5% |
Revised scoring system |
| 37 with PBC |
7 |
19% |
| Joshi et al. [39] |
2002 |
331 |
16 |
5% |
Paris criteria |
| Muratori et al. [36] |
2002 |
142 |
3 |
2% |
Revised scoring system |
| Talwalkar et al. [43] |
2002 |
137 |
26 |
19% |
Revised scoring system |
| Yamamoto et al. [54] |
2003 |
48 with AIH |
4 |
8% |
PBC scoring system |
| Gheorghe et al. [48] |
2004 |
82 with AIH |
11 |
13% |
Paris criteria |
| Chazouilleres et al. [37] |
2006 |
190 |
17 |
9% |
Paris criteria |
| Poupon et al. [38] |
2006 |
282 |
39 |
14% |
Paris criteria/Revised scoring system |
| Heurgue et al. [40] |
2007 |
115 |
15 |
13% |
Paris criteria |
| Neuhauser et al. [47] |
2009 |
368 with PBC |
43 |
12% |
Revised scoring system |
| 23 |
6% |
Simplified scoring system |
| Bonder et al. [52] |
2011 |
209 |
6 |
1% |
Paris criteria |
| 17 |
3% |
“Expanded” Paris criteria |
| Tanaka et al. [53] |
2011 |
597 with PBC |
33 |
6% |
“Modified” Revised scoring system |
| 1081 with AIH |
33 |
3% |
Notes: Paris criteria-see Table 1; Revised scoring system-see Table 2; Simplified scoring system-see Table 3; PBC scoring criteria, “Expanded” Paris criteria, “Modified
Revised scoring system-see references. |
